Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Evaluation of a Remote Behavioural Stress Recovery Intervention for Myocardial Infarction Patients Younger Than Fifty-five (BRIM-55): A Feasibility Study (BRIM-55)

15 de julho de 2026 atualizado por: Erik Olsson, Uppsala University

The goal of this feasibility study is to learn if the randomised controlled trial evaluating the Remote-delivery Balance in Everyday Life (rBEL) programme for adults younger than 55 years who have experienced a myocardial infarction (MI), is feasible.

The objective is to examine the feasibility of the rBEL programme and the associated study procedures before a controlled evaluation of the programme. This is an uncontrolled, single-arm, pre-post treatment designed study.

Participants of the target population will take part of the six session over 13 week programme. Feasibility will be evaluated against predefined feasibility criteria regarding study procedures and programme acceptability.

Visão geral do estudo

Descrição detalhada

BACKGROUND Even though there have been major improvements in medical treatments resulting in considerably lower mortality rates, cardiovascular diseases (CVDs) remain the leading cause of death and the main cause of loss of disability-adjusted life-years worldwide. Myocardial infarction (MI) is the most common of the serious CVDs. While the total number of MIs has decreased during the last decades, the proportion of young patients hospitalized with MI has increased.

Cardiac distress (CD) summaries the psychological impacts of a cardiac event and expands on the general "psychological distress" concept (i.e. symptoms of depression and anxiety). Cardiac distress is common after an MI. For young persons, having an MI is particularly stressful and the prevalence of anxiety and depression is more than double compared to that of older patients.

Conventional stress management intervention programs are based on a "reactivity paradigm", with techniques used to reduce, avoid, or change the interpretation of the stressors and/or stress responses associated with distress. An alternative, contrasting strategy is to address recovery processes. To the best of our knowledge, the intervention program Balance in Everyday Life (BEL), based on cognitive behavioural principles, has the best empirical support.

Guidelines for cardiac rehabilitation recommend screening of psychosocial aspects but interventions in this area are very rare in clinical practice.

METHOD Aim The aims are to assess feasibility and acceptability of the iBEL program for post-myocardial infarction survivors aged below 55 years reported ongoing CD, and the study procedures of the later evaluation study.

Research Questions

  1. How feasible is the study procedures of the planned evaluation study in terms of recruitment, retention and adherence rates?
  2. To what extent is the iBEL program perceived as acceptable to young post-MI survivors, in terms of its content, delivery method and relevancy?

Design An uncontrolled, single-arm, pre-post treatment design.

Participants Thirty participants of the target population will be included. Exclusion criteria: (i) not being able to read, write or speak Swedish, (ii) being able to use the digital device necessary for participation and (iii) early retirement or disability pension at the time of the MI.

Procedure Participants will be recruited via a register extraction from SWEDEHEART of all persons having an MI before the age of 55 one year before intervention start. Preliminary eligible participants will be sent an invitation letter primarily via a digital post-box with a description of the study and an option to register interest for the study. To qualify as participants with CD, they must state they have at least experienced moderate distress as a consequence of their MI which impairs day-to-day recovery, and they believe psychological support will benefit them. They are then asked to provide written consent.

The Program The program consists of 6 sessions spread out over 13 weeks. Each session includes a video-call meeting online, via the platform Zoom, with a therapist. The therapists are healthcare workers (clinical social workers-LCSW, MSW specialized in psychotherapy, nurses psychiatric/mental health nurse practitioners- PMHNPs, occupational therapists with mental health specialization) with training in clinical conversations or students recruited from the final semesters of the university programs for psychologists or physiotherapists with basic training in clinical conversations. They will be trained in the rBEL program and receive supervision by a senior therapist. Before each data collection time-point, participants will be prompted and, if necessary, reminded to report via SMS and/or e-mail, based on their preference, and thereafter, if needed, via telephone.

In addition to this meeting with the therapist there is psychoeducational material on a website (www.brim55.se) and a printed booklet for exercise notations.

Data analysis The feasibility results will be evaluated against pre-specified progression criteria. The sample size (N=30) is based on a rule-of-thumb for feasibility studies and is judged to be enough for detecting feasibility concerns.

Tipo de estudo

Intervencional

Inscrição (Estimado)

30

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

      • Uppsala, Suécia, 752 37
        • Uppsala University
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion criteria:

  • Myocardial infarction (MI) before age 55 years
  • MI within one year prior to randomization
  • Report of subjective cardiac distress in the initial interview

Exclusion criteria:

  • Serious conditions hindering participation (e.g., active substance misuse, severe mental illness)
  • Insufficient Swedish proficiency for study procedures,
  • Disability pension or early retirement at the time of MI

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Remote-delivery Balance in Everyday Life (rBEL) intervention group
Participants randomized to this arm will receive the Remote-delivery Balance in Everyday Life (rBEL) program, a therapist-supported behavioral stress recovery intervention delivered over 12 weeks. The program includes six individual online sessions, a printed workbook containing exercises and self-monitoring materials, and access to online video resources. The intervention is designed to promote recovery behaviors, improve stress regulation, and reduce cardiac distress following myocardial infarction.
The Remote-delivery Balance in Everyday Life (rBEL) program is a 13-week therapist-supported behavioral stress recovery intervention for adults younger than 55 years who have experienced a myocardial infarction and report cardiac distress. The program includes six individual online sessions delivered by a therapist, a printed exercise workbook, and online video materials. The content focuses on recovery behaviors, relaxation training, self-monitoring, use of recovery strategies in daily life and work settings, and management of heart-related worry and anxiety.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Recruitment
Prazo: Six weeks from when the invitation letter was sent out

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.

Green: ≥8% of the invited population starting intervention. Yellow: <8% and ≥6%. Red: <6%.

Six weeks from when the invitation letter was sent out
Acceptability
Prazo: Four weeks from the screening interview

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.

Green: ≥75% of eligible participants consent. Yellow: <75% and ≥60%. Red: <60%.

Four weeks from the screening interview
Participant adherence
Prazo: From start of intervention to 12 weeks later.

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.

Green: ≥70% of the participants completing a minimum of 4 sessions with the therapist.

Yellow:<70% and ≥60%. Red: <60%

From start of intervention to 12 weeks later.
Retention
Prazo: From the end of the intervention to two weeks later.

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.

Green: ≥90% complete data on the CDI, post-treatment. Yellow: <90% and ≥75%. Red: <75%.

From the end of the intervention to two weeks later.
Adverse events
Prazo: From intervention start to four weeks after intervention end.

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.

Green: no inconveniences or adverse events linked to study participation reported.

Yellow: ≤ 2 reports of inconveniences (comparable to max 2 days of increased fatigue, stress or worry).

Red: any adverse event or more than 3 inconveniences reported linked to study participation

From intervention start to four weeks after intervention end.
Program credibility
Prazo: Rating is done after first intervention session (first week of intervention). A two week submission period is allowed.

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. The credibility subscale of the Credibility and Expectancy Questionnaire has a max score of 27. A higher score means more credibility.

Green: ≥75% of participants rate the credibility subscale of CEQ ≥ 7. Yellow: ≥75% rate it < 7 and ≥ 5. Red: >25% rate it < 5.

Rating is done after first intervention session (first week of intervention). A two week submission period is allowed.
Program satisfaction
Prazo: From the end of the intervention to two weeks later.

The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. The Client Satisfaction Questionnaire 8 items version (CSQ-8) has a max score of 32 where a higher score means more satisfaction.

Green: ≥ 75% of participants score ≥26 on the CSQ-8. Yellow: ≥ 75% rate it ≥24. Red: > 25% rate it <24.

From the end of the intervention to two weeks later.

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Cardiac distress
Prazo: Mid intervention (CDI short form): After session 3 (2 week submission period) After intervention: From the end of the intervention to two weeks later.
Cardiac Distress Inventory (CDI)
Mid intervention (CDI short form): After session 3 (2 week submission period) After intervention: From the end of the intervention to two weeks later.
Recovery Experience
Prazo: Mid intervention: After session 3 (2 week submission time frame). After intervention: From the end of the intervention to two weeks later.
The Recovery Experience Questionnaire (REQ) has a max score of 80 where a higher score means more recovery.
Mid intervention: After session 3 (2 week submission time frame). After intervention: From the end of the intervention to two weeks later.
Health-related quality of life
Prazo: From the end of the intervention to two weeks later.
The HeartQoL instrument has a max score of 42 where a higher score means better quality of life.
From the end of the intervention to two weeks later.
Depression
Prazo: From the end of the intervention to two weeks later.
The Patient Health Questionnaire, 9 items (PHQ-9) has a max score of 27. A higher score means more depressed.
From the end of the intervention to two weeks later.
Anxiety
Prazo: From the end of the intervention to two weeks later.
The instrument General Anxiety Disorder, 7 items version (GAD-7) has a max score of 21. A higher score means more anxiety.
From the end of the intervention to two weeks later.
Working ability
Prazo: From the end of the intervention to two weeks later.
Work Ability Index has a max score of 49 where a higher score means better working ability.
From the end of the intervention to two weeks later.
Healthcare costs
Prazo: From the end of the intervention to two weeks later.
The instrument Treatment Inventory of Costs in Patients with psychiatric disorders, Midi version (TIC-P Midi) counts visits in health care. The more visits the higher the costs. Visits to specialists and hospital stays means higher costs than outpatient visits.
From the end of the intervention to two weeks later.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Erik Olsson MG Olsson, Professor, Uppsala University

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

24 de agosto de 2026

Conclusão Primária (Estimado)

31 de janeiro de 2027

Conclusão do estudo (Estimado)

30 de junho de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

2 de julho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

15 de julho de 2026

Primeira postagem (Real)

16 de julho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de julho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

15 de julho de 2026

Última verificação

1 de julho de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Due to the European data protection law, this will not be allowed without a special ethical approval.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever